Breadcrumbs

Freedom of information disclosure log

This log lists information released by the Gene Technology Regulator under the Freedom of Information Act 1982 that is available for public access.

26 results
FOI number FOI release date Information requested
033-2020

Evidence used when reaching the decision that the applicant for Licence DIR 173 is suitable to hold that licence.

030-2020

Annual and occasional reports lodged with the OGTR up to and during 2020, in fulfillment of conditions in the licences DIR 157, DIR145, DIR143, DIR124, DIR118, DIR091, DIR066 and DIR062, for commercial release of genetically manipulated cotton.

031-2020

Annual and occasional reports lodged with the OGTR up to and during 2020 in fulfillment of conditions in the licences DIR 155, DIR139 and DIR138, and DIR127 for release of commercial genetically manipulated canola.

032-2020

Annual and occasional reports lodged with the OGTR during 2020 in fulfilment of conditions in the licences DIR020, DIR021 and DIR108, for release of commercial genetically manipulated canola.

028-2020

Annual and occasional reports lodged with the OGTR during 2018 and 2019 in fulfillment of conditions in the licences DIR 020, DIR 021 and DIR 108, for release commercial GM canola.

026-2018

Annual and occasional reports lodged with the OGTR since 1 December 2017 to meet the conditions in the licences DIR 020, DIR 021 and DIR 108, to release commercial GM canola.

023-2018

All annual and occasional reports that the licensee has lodged with the OGTR during 2017 and/or 2018 to meet conditions in the licence DIR-108, for release of commercial genetically manipulated canola.

021-2018

All correspondence discussing the regulation of RNA interference, null segregants and SDN-1 techniques in Australia between the OGTR and a range of individuals and institutions, from January 2015.

019-2017

Annual and occasional reports lodged by licensees to OGTR during 2016 – 2017 in fulfilment of licence conditions for DIR-020 (Monsanto Australia Ltd, GM canola), DIR-021(Bayer CropScience Pty Ltd, GM canola) and DIR-108 (Bayer Crop Science Pty Ltd, GM canola).

017-2017

All communication since January 2014 from the Gene Technology Technical Advisory Committee (GTTAC) to the Gene Technology Regulator regarding new plant breeding techniques.

014-2017

All annual reports submitted to the OGTR during timeframes stipulated by the applicant and any correspondence sent by the OGTR to local authorities regarding compliance issues for licences DIRs 133, 114, 120 and DNIRs 386 and 478. Additionally, any reports that describe the incident highlighted in the OGTR's March 2013 quarterly report DIR 114.

015-2017

All documents contained within the file “E16-613 Nuseed incidents” as outlined on the departmental records listing for January – June 2016.

013-2016

All annual reports that the licensee has lodged with the OGTR in fulfilment of this condition in licence DIR 126. All reports of significant adverse events arising from the conduct of DIR 126 trials.

011-2016

All annual and occasional reports that the licensees have lodged with the OGTR during 2015 and 2016 in fulfillment of conditions in the licences DIR 020, DIR 021 and DIR 108, for release of commercial genetically manipulated canola.

009-2016

All correspondence with non-governmental organisations, for profit companies, academic and research institutions, individuals, the US Government and the Department of Foreign Affairs and Trade relating to whether several new techniques are currently subject to regulation or should be subject to regulation in Australia.

010-2016

Seek access to all documents pertaining to application DIR 072/2007 Commercial release of GloFish expressing red, green or yellow fluorescent proteins made by Yorktown Technologies.

007-2016

All the annual reports that licences have lodged with the OGTR since 1996, in fulfilment of conditions in all licences issued for commercial release of genetically manipulated cotton, including licences DIR 102, DIR 062, DIR 066, DIR 091, DIR 118 and DIR 124 and including all others that may exist.

006-2015

All documents relating to the forthcoming public consultation process on New Plant Breeding Techniques.

005-2015

All annual and occasional reports that the licensees have lodged with the OGTR during 2014 and 2015 in fulfilment of conditions in the licences DIR 020, DIR 021 and DIR 108, for release of commercial genetically manipulated canola.

004-2015

All documents relating to the OGTR’s Advice to Dow AgroSciences in 2012 regarding the regulatory status of its EXZACT Delete technology. All documents from January 2014 to the present regarding oligo-directed mutagenesis: nuclease-mediated site-directed mutagenesis – including zinc-finger nucleases, transcription activator-like nucleases, and CRISPR/Cas-nucleases; and cisgenesis and intragenesis. All documents relating to the planned public consultation process on New Plant Breeding Techniques this year, including the techniques mentioned above.

003-2014

The documentation sought is all documents, including transcripts of all interviews, in relation to the reporting and subsequent investigation of two incidents reported to the Office of the Gene Technology Regulator concerning incidents that occurred at the University of Queensland.

002-2014

Request OGTR to publish the name, registration and formulation of the herbicide to be used on sugarcane in the proposed DIR 129 trials.

001-1014

Annual and other reports lodged by the licensees, in fulfillment of conditions in the licences DIR020 and DIR021 for release of commercial genetically manipulated canola.

Reports in fulfillment of any licences and their requirements for commercial GM canola that may have superceded DIR020 and DIR021, including replacement licences or licence variations.

001-2013

Copies of advice received from, correspondence with, or notes of conversations with Professor Peter Langridge, formal and informal, whether solicited or volunteered on the following approvals (or comments he provided on submissions by others on these approvals):

  • DIR093
  • DIR099
  • DIR112
  • DIR117

Any responses provided to OGTR from CSIRO to the Centre for Integrated Research reports on testing for potential adverse effects of dsRNA molecules in DIR093 and DIR112.

080-112

Documents relating to research into the Health effects (beneficial or otherwise) of genetically modified wheat products. No documents older than 5 years need be included. No Public documents need to be included.

191-1011

Any applications for certification of a facility or private farm under section 83 of the Gene Technology Act in the Shire of Corrigin, WA, Shire of Merredin, WA, and Redland City, QLD.
Documents should be from 2004 to the present.